Cato T. Laurencin - Jun 13, 2023 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

Role: Director
Signature: /s/ William F. Hulse as attorney-in-fact for Cato T. Laurencin
Stock symbol: MDXG
Transactions as of: Jun 13, 2023
Transactions value $: $175,002
Form type: 4
Date filed: 6/15/2023, 06:10 PM
Previous filing: Jun 8, 2023
Next filing: Jun 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDXG	Common Stock	Award	$175K	+35.4K	+37.31%	$4.95	130K	Jun 13, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.